Tianzuo Zhan

6PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 14, 2023
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.

Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience

|Mar 29, 2023
The Roles of Secreted Wnt Ligands in Cancer.

Johannes Werner, Kim E Boonekamp, Tianzuo Zhan

|Jun 06, 2022
Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.

Leonhard Valentin Bamberg, Florian Heigwer, Anna Maxi Wandmacher

|Apr 03, 2021
Prognostic Cancer Gene Expression Signatures: Current Status and Challenges.

Yuquan Qian, Jimmy Daza, Timo Itzel

|Nov 13, 2020
Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155.

Tianzuo Zhan, Verena Faehling, Benedikt Rauscher

Pageof 1